These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells. Almstedt M, Blagitko-Dorfs N, Duque-Afonso J, Karbach J, Pfeifer D, Jäger E, Lübbert M. Leuk Res; 2010 Jul; 34(7):899-905. PubMed ID: 20381863 [Abstract] [Full Text] [Related]
4. Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications. Coral S, Sigalotti L, Colizzi F, Spessotto A, Nardi G, Cortini E, Pezzani L, Fratta E, Fonsatti E, Di Giacomo AM, Nicotra MR, Natali PG, Altomonte M, Maio M. J Cell Physiol; 2006 Apr; 207(1):58-66. PubMed ID: 16252259 [Abstract] [Full Text] [Related]
9. Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2'-deoxycytidine in glioma cells. Oi S, Natsume A, Ito M, Kondo Y, Shimato S, Maeda Y, Saito K, Wakabayashi T. J Neurooncol; 2009 Mar; 92(1):15-22. PubMed ID: 19030781 [Abstract] [Full Text] [Related]
13. De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y, Zeng G, Wunderlich JR, Nguyen DM, Restifo NP, Schrump DS. Cancer Res; 2006 Jan 15; 66(2):1105-13. PubMed ID: 16424047 [Abstract] [Full Text] [Related]
14. A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression. Gunda V, Frederick DT, Bernasconi MJ, Wargo JA, Parangi S. Thyroid; 2014 Aug 15; 24(8):1241-50. PubMed ID: 24811699 [Abstract] [Full Text] [Related]
15. NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine. Pollack SM, Li Y, Blaisdell MJ, Farrar EA, Chou J, Hoch BL, Loggers ET, Rodler E, Eary JF, Conrad EU, Jones RL, Yee C. PLoS One; 2012 Aug 15; 7(2):e32165. PubMed ID: 22384167 [Abstract] [Full Text] [Related]
18. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma. Everson RG, Antonios JP, Lisiero DN, Soto H, Scharnweber R, Garrett MC, Yong WH, Li N, Li G, Kruse CA, Liau LM, Prins RM. Neuro Oncol; 2016 Mar 15; 18(3):368-78. PubMed ID: 26330563 [Abstract] [Full Text] [Related]
19. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Bender CM, Pao MM, Jones PA. Cancer Res; 1998 Jan 01; 58(1):95-101. PubMed ID: 9426064 [Abstract] [Full Text] [Related]
20. [Effects of 5-aza-2'-deoxycytidine on the amount of exosomes and secreted immuno-associated proteins by hepatoma cells]. Sanrengaowa, Wu Y, Xiao WH. Zhonghua Zhong Liu Za Zhi; 2009 Jul 01; 31(7):495-9. PubMed ID: 19950695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]